Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

etoposide

  • Open Access
    Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix
    AI MIYOSHI, YUTAKA UEDA, TOMOKO KURITA, TADASHI KIMURA and KIYOSHI YOSHINO
    Anticancer Research April 2023, 43 (4) 1397-1405; DOI: https://doi.org/10.21873/anticanres.16288
  • You have access
    Etoposide-induced MicroRNA-205-5p Suppresses Proliferation and Migration by Targeting ERBB4 in MCF-7 Cells
    SEUNG WAN SON, SEUNG HYEOK HEO, SANG SU OH, CHAN HEE LEE and JONG KOOK PARK
    Anticancer Research September 2022, 42 (9) 4265-4272; DOI: https://doi.org/10.21873/anticanres.15926
  • You have access
    Preclinical Evaluation of Combined Topoisomerase and Proteasome Inhibition Against Pediatric Malignancies
    EDVIN DESTANOVIC, JOACHIM BOOS and CLAUDIA LANVERS-KAMINSKY
    Anticancer Research July 2018, 38 (7) 3977-3984; DOI: https://doi.org/10.21873/anticanres.12684
  • You have access
    Application of Albumin-embedded Magnetic Nanoheaters for Release of Etoposide in Integrated Chemotherapy and Hyperthermia of U87-MG Glioma Cells
    MELÁNIA BABINCOVÁ, HANA VRBOVSKÁ, PAUL SOURIVONG, PETER BABINEC and ŠTEFAN DURDÍK
    Anticancer Research May 2018, 38 (5) 2683-2690;
  • You have access
    Effect of MPS1 Inhibition on Genotoxic Stress Responses in Murine Tumour Cells
    MOTOFUMI SUZUKI, TOHRU YAMAMORI, HIRONOBU YASUI and OSAMU INANAMI
    Anticancer Research June 2016, 36 (6) 2783-2792;
  • You have access
    Ifosfamide and Etoposide Chemotherapy in the Treatment of Recurrent/Refractory Rhabdomyosarcoma in Adults
    SHINSUKE SASADA, MAKOTO KODAIRA, TATSUNORI SHIMOI, AKIHIKO SHIMOMURA, MAYU YUNOKAWA, KAN YONEMORI, CHIKAKO SHIMIZU, YASUHIRO FUJIWARA and KENJI TAMURA
    Anticancer Research May 2016, 36 (5) 2429-2432;
  • You have access
    Cisplatin Plus Ifosfamide with/without Etoposide as Salvage Treatment in Heavily-pre-treated Patients with Metastatic Breast Cancer
    PIET HABBEL, ANNIKA KURRECK, CARSTEN-OLIVER SCHULZ, ANNE CONSTANZE REGIERER, DAVID KAUL, CHRISTIAN WILFRIED SCHOLZ, CHRISTIAN NEUMANN, KURT POSSINGER and JAN EUCKER
    Anticancer Research September 2015, 35 (9) 5091-5095;
  • You have access
    A Pilot Study of Cisplatin and Etoposide With and Without Radiotherapy for Advanced Malignant Thymoma
    AKIHIRO TAMIYA, AKIHIDE MATSUMURA, TAISUKE TSUJI, MASAHIRO MORIMOTO, KAZUHIRO ASAMI, KYOICHI OKISHIO, SHIGEKI SHIMIZU, HYUNG-EUN YOON, SHINJI ATAGI, MASANORI AKIRA, MASANORI KITAICHI and TOMOYA KAWAGUCHI
    Anticancer Research April 2014, 34 (4) 2023-2027;
  • You have access
    Acquired Resistance to Chemotherapy in Lung Cancer Cells Mediated by Prolonged Nitric Oxide Exposure
    PIYAPARISORN WONGVARANON, VARISA PONGRAKHANANON, PREEDAKORN CHUNHACHA and PITHI CHANVORACHOTE
    Anticancer Research December 2013, 33 (12) 5433-5444;
  • You have access
    Phase I Trial of Carboplatin and Etoposide in Combination with Panobinostat in Patients with Lung Cancer
    AHMAD A. TARHINI, HARIS ZAHOOR, BRIAN MCLAUGHLIN, WILLIAM E GOODING, JOHN C. SCHMITZ, JILL M. SIEGFRIED, MARK A. SOCINSKI and ATHANASSIOS ARGIRIS
    Anticancer Research October 2013, 33 (10) 4475-4481;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire